BRIEF-Revolution Medicines Q2 EPS USD -1.31

Reuters
Aug 07
BRIEF-<a href="https://laohu8.com/S/RVMD">Revolution Medicines</a> <a href="https://laohu8.com/S/QTWO">Q2</a> EPS USD -1.31

Aug 06 (Reuters) - Revolution Medicines Q2 operating expenses USD 264.714 million.

  • Q2 net income USD -247.787 million
  • Q2 operating income USD -264.714 million
  • Q2 pretax profit USD -247.787 million
  • outlook FY net income USD -1,090 to -1,030 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10